IRIS (R) Mol. Diagnostics platform for AMR

A novel diagnostics platform for customized molecular diagnostics for AMR.

The only product specifically designed for the needs of Latin America hospitals, for screening of AMR genes and Candida among hospitalized patients (adults, children and neonates)

Technology:
  • Infection prevention
  • Antimicrobial stewardship
  • Microbial diagnostics
  • Antimicrobial compound/strategy
  • Removal antibiotics/bacteria

Microorganisms:
  • Bacteria
  • Fungi
  • Viruses
  • Yeasts
  • Parasites

Application:
  • Human
  • Veterinary
  • AgriFood
  • Environmental
  • Other

Development stage:
  • Development
  • Validation
  • Research
  • Market entry
  • Marketed product

Organization:
  • Company
  • Academia
  • Institute
  • NGO
  • Government

Partnering:
  • Co-develop
  • Joint Venture
  • License
  • Outsource
  • Sell

Funding organisation:
  • OTHER / NA
  • CARB-X
  • FIND
  • GARDP
  • REPAIR

Infectious disease area:
  • BSI
  • GII
  • UTI
  • STI
  • RTI
  • SSTI
  • CNSI
  • IAI
  • SSI

Geographic origin:
  • South America
  • North America
  • Eurasia
  • Africa
  • Oceania


Interested in non-refundable funds and smart investment from Venture Capital funds, NGOs or individuals.

Biotechnology company with proprietary molecular diagnostics platform, focused on customized AMR diagnostics.

Custom made diagnostic kits for Pharmacogenomics


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed